Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study

Background: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where data are limited. Methods: A case–control study included individuals aged ≥18 years, unvaccinated or received two to three doses of CoronaVac/BNT162b2,...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Philip Hei Li, Tiantian Ma, Simon Qin, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2023-12-01
Schriftenreihe:	Emerging Microbes and Infections
Schlagworte:	COVID-19 waning vaccine effectiveness CoronaVac BNT162b2 Omicron
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/22221751.2023.2209201
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!